Probiotics for SIBO – Do they Help or Harm?

, , , , , , , , , , ,

If you've been struggling with SIBO (Small Intestinal Bacterial Overgrowth), you may be familiar with the uncomfortable symptoms, such as bloating, gas, pain, and unpredictable bowel movements, which can make everyday life a challenge.

Naturally, you want relief. But when it comes to probiotics for SIBO, the advice is all over the place. Some people swear by them, while others warn that probiotics could worsen symptoms by feeding the overgrowth.

So, what's the real answer? Can probiotics help with SIBO, or should you avoid them completely?

Best probiotics for SIBO - guide

What is SIBO, and how does it feel?

SIBO happens when bacteria that should stay in the large intestine start growing in the small intestine. Since the small intestine is designed for nutrient absorption—not fermentation—this overgrowth can cause major digestive issues. (1)

Common SIBO symptoms:

  • Bloating (especially after eating)
  • Gas and distension
  • Diarrhea, constipation, or both
  • Nutrient deficiencies (B12, iron, fat-soluble vitamins)
  • Abdominal pain and discomfort
  • Brain fog and fatigue
  • Muscle and joint pain
  • Skin issues (eczema, rosacea, acne)

SIBO is often misdiagnosed as IBS because the symptoms overlap. However, IBS treatments don't always work for SIBO because they don't address bacterial overgrowth.

The underlying reasons for SIBO can also be many things, from impaired gut motility, insufficient digestive juice production, infections, and structural problems.

The Ultimate Guide to SIBO - eBook by SeekingGutHealthDOWNLOAD THE FREE ULTIMATE SIBO GUIDE

Imagine taking back control of your body and living bloat-free.

Download your free guide and discover the 5 BIGGEST mistakes people make when trying to heal SIBO (and the steps to avoid them).

Grab your copy today.

Yes, I need this!

What are probiotics?

Probiotics are live microorganisms—mainly beneficial bacteria and yeasts—that support gut health when consumed in the right amounts. The word "probiotic" comes from the Greek "pro bios," meaning "for life."

Unlike harmful bacteria that cause infections, probiotics help balance your gut microbiome and promote better digestion, immunity, and overall health.

Probiotics benefit the gut by:

  • Crowding out harmful bacteria – By competing for space and nutrients, probiotics can prevent the overgrowth of pathogenic bacteria.
  • Enhancing digestion – Certain strains help break down food, absorb nutrients, and even produce vitamins like B12 and K2.
  • Supporting gut barrier function – They strengthen the gut lining, reducing leaky gut and inflammation.
  • Producing beneficial compounds – Many probiotics create short-chain fatty acids (SCFAs) and antimicrobial substances that support gut health.
  • Regulating the immune system – A balanced microbiome prevents excessive immune reactions, helping conditions like IBS, allergies, and autoimmune disorders.
  • and many more benefits (2) (3) (4) (5)

Types of probiotics

Probiotics come in various strains, each with different benefits.

The most common types include:

  • Lactobacillus & Bifidobacterium – Found in yogurt, kefir, and supplements. They aid digestion and boost immunity.
  • Saccharomyces boulardii – A probiotic yeast that fights harmful bacteria and supports gut healing.
  • Soil-based probiotics (Bacillus species) – Hardy strains that survive stomach acid and support microbiome balance. (6)

Probiotics for SIBO – is it a yes or a no?

The biggest concern with probiotics and SIBO is that you're adding more bacteria to an overgrowth situation. Wouldn't that make things worse?

Why some experts say to avoid probiotics for SIBO:

  • Many probiotics contain Lactobacillus and Bifidobacterium, which may colonize the small intestine and worsen bloating.
  • Some strains (e.g., Lactobacillus bulgaricus, L. casei, Streptococcus thermophilus, etc.) increase histamine, triggering inflammation. (7)
  • Multi-strain probiotics might exacerbate symptoms instead of helping.
  • Certain ingredients in these products may worsen symptoms, such as prebiotics,  starches, lactose, maltodextrin, etc.

Why some experts recommend probiotics for SIBO:

  • Certain probiotic strains produce antimicrobial compounds that fight bad bacteria. (8)
  • Some probiotics help improve gut motility, preventing bacterial stagnation. (9)
  • Probiotics may reduce inflammation, enhance gut barrier function, supporting gut healing. (10)

The best probiotic strains for SIBO

The key to using probiotics for SIBO is choosing the right strains. Research suggests that certain probiotics can reduce symptoms and even help prevent SIBO relapse.

Are there promising results that probiotics for SIBO are effective?

A pilot study compared the effectiveness of metronidazole (Flagyl) (a common antibiotic used in methanogen overgrowth) vs. a probiotic blend in 50 patients with SIBO and chronic abdominal distension.

They found that

  • 82% of patients taking the probiotic reported symptom improvement, compared to 52% in the antibiotic group—a statistically significant difference (P = 0.036).
  • The probiotic contained Lactobacillus casei, Lactobacillus plantarum, Streptococcus faecalis, and Bifidobacterium brevis (Bioflora).
  • No major side effects were reported in either group.

This study suggests that probiotics may be more effective than metronidazole for improving SIBO-related bloating and abdominal distension in the short term. While more research is needed, probiotics could be a promising alternative or complementary approach to antibiotics in SIBO treatment. (11)

Another study investigated the effects of Bacillus clausii in patients with SIBO diagnosed via hydrogen breath test (HBT). In this study, patients were given Bacillus clausii (a spore-forming probiotic) for treatment. Results showed that Bacillus clausii normalized hydrogen breath tests at rates comparable to antibiotics. Patients also experienced symptomatic relief, particularly in bloating and gas production. (12)

The best probiotic strains for SIBO

Let's look at the various strains that show promising results

Lactobacillus reuteri DSM 17938

  • This probiotic strain has been found to have a beneficial effect on chronic constipation by massively decreasing methane production and improving gut motility. (13)
  • It was found to reduce abdominal pain in children. (14)
  • It has also been shown to prevent SIBO occurrence in patients taking proton pump inhibitors (PPIs) (a medication used to reduce stomach acid production). (15)
  • reuteri also has antimicrobial (produce Reuterin and other substances) properties and is effective against Helicobacter pylori, E. Coli, Clostridium difficile, and Salmonella infection. It has been suggested that L. reuteri has antiviral components and antifungal properties against Candida species and can reduce inflammation. (16)
  • It can produce vitamin B12 (cobalamin) and B9 (folate), which are often low in patients with SIBO. (16)

Most studies use 1 × 10⁸ to 2 × 10⁸ CFU (colony-forming units) per day. This is typically delivered in one or two doses daily.

Research suggests that taking Lactobacillus reuteri DSM 17938 for 4–8 weeks may provide benefits, especially for reducing methane production and improving gut motility in SIBO patients​. (17)

An example product is BioGaia Protectis Drops (5 drops per day, which provides 1 × 10⁸ CFU of Lactobacillus reuteri DSM 17938).

Or BioGaia Gastrus that contains 200 million CFU (2 × 10⁸ CFU) per tablet of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475. Typically used for gut motility, methane overgrowth, and H. pylori support. (for more clinical studies, check out this guide created by >>Biogaia<<

Bifidobacterium lactis HN019

  • This strain has been found to improve gut motility and bowel movement frequency in cases of functional constipation (18)
  • It reduces bloating and gas by rebalancing gut bacteria (19)
  • It has been reported to reduce the frequency of functional gastrointestinal symptoms in adults, including abdominal pain, nausea, constipation, diarrhea, and flatulence (17)

Clinical studies have used 1 × 10⁹ to 1 × 10¹⁰ CFU (1–10 billion CFU) per day for gut motility and digestive benefits. Some studies have used up to 17.2 billion CFU per day for improving gut transit time (19)

4–8 weeks is the typical study duration for improving constipation and bloating. Some trials suggest effects may be seen as early as 14 days, but the best results occur after a month or more.

An example of products could be Life Extension, Florassist® Probiotic, Daily Bowel Regularity.

Lactobacillus plantarum 299v

Lactobacillus plantarum 299v (LP299V) is a well-researched probiotic strain, particularly for gut health, IBS, and inflammatory conditions.

Potential benefits for SIBO & gut health:

  • Reduces bloating and abdominal pain in IBS patients - A randomized controlled trial found that LP299V significantly reduced bloating and pain in IBS patients (20)
  • Strengthens gut barrier function (reduces leaky gut) - LP299V has been shown to improve intestinal permeability, helping strengthen the gut barrier in stressed individuals (21). Many SIBO patients have leaky gut, which can worsen inflammation and food intolerances.
  • Reduces inflammation and modulates immune response - LP299V has been shown to lower inflammatory markers like TNF-α and IL-6 in patients with IBS (22). Chronic inflammation is common in SIBO due to bacterial toxins; LP299V may help reduce this.

Most clinical studies use 5 × 10^9 to 1 × 10^10 CFU per day (up to 100 billion CFU) per day.

Research suggests taking LP299V for 4–12 weeks provides the most benefits for gut motility, inflammation, and bloating relief. (23),(24)

An example product is Jarrow Formulas, Vegan Ideal Bowel Support, 10 Billion CFU.

Saccharomyces boulardii

Saccharomyces boulardii (S. boulardii) is a unique probiotic yeast that has been widely studied for gut health, diarrhea, and microbiome restoration. Unlike bacterial probiotics (like Lactobacillus and Bifidobacterium), S. boulardii is a non-colonizing yeast, meaning it doesn't stay in the gut long-term—it works while you take it and is eliminated within a few days after stopping supplementation.

This makes S. boulardii particularly useful in SIBO treatment, as it does not contribute to bacterial overgrowth but still provides key gut-supportive benefits. (25)

  • Supports SIBO antibiotic therapy without being destroyed - unlike bacterial probiotics, boulardii is not affected by antibiotics, making it an excellent choice during or after SIBO antibiotic treatment. A clinical trial showed that adding S. boulardii to antibiotic treatment like metronidazole improved SIBO eradication rates compared to antibiotics alone. (26)
  • In another study, in patients with decompensated cirrhosis, a 3-month course of S. boulardii eliminated SIBO in 80% of cases, compared to 23.1% in a placebo group. (27)
  • Reduces digestive symptoms - S. boulardii has been shown to reduce diarrhea and antibiotic-associated diarrhea significantly. (28) Hydrogen-dominant SIBO is often associated with chronic diarrhea, and S. boulardii can help regulate stool consistency.
  • Clinical trials show that adding S. boulardii to antibiotic therapy can improve SIBO-related diarrhea and abdominal pain faster than antibiotics alone (29).
  • A meta-analysis found another type of yeast, Saccharomyces cerevisiae (S. Cerevisiae CNCM I-3856), to significantly improve abdominal pain and discomfort, bloating, as well as stool consistency in IBS patients. (30)
  • Modulates the immune system & reduces gut inflammation – S. boulardii was shown to reduce pro-inflammatory cytokines (IL-6, TNF-α) and improve gut immune function. (31) Why does this matter for SIBO? Because SIBO triggers gut inflammation, leading to bloating, food sensitivities, and leaky gut. S. boulardii helps calm the immune response and protect the gut lining.
  • Supports gut microbiome balance - One of the biggest challenges in SIBO treatment is that antibiotics can kill both harmful and beneficial bacteria, leading to gut dysbiosis and a higher risk of relapse. Since S. boulardii is a yeast and not a bacterium, it is resistant to antibiotics and can help restore gut balance during and after antibiotic treatment. A randomized trial found that boulardii protected the gut microbiome from antibiotic-induced dysbiosis in healthy volunteers (32). A clinical study on patients with SIBO and IBS-D found that S. boulardii supplementation reduced harmful bacteria (Proteobacteria) and increased beneficial anti-inflammatory microbes (F. prausnitzii) (29)
How Saccharomyces boulardii is different from bacterial probiotics
Saccharomyces boulardii vs bacterial probiotics

Key takeaway: S. boulardii is ideal for SIBO patients undergoing antibiotic treatment or those who want symptom relief without increasing bacterial overgrowth.

The general recommended dosage:

  • Standard dose: 250–500 mg per day (equivalent to 5–10 billion CFU per day).
  • Higher doses (up to 1,000 mg per day) have been used in some studies for diarrhea and gut inflammation.

Duration:

  • During antibiotic therapy: Take S. boulardii alongside antibiotics to prevent dysbiosis and increase the rate of eradication of SIBO.
  • Post-SIBO treatment: Continue for 4–8 weeks to support microbiome recovery.
  • For chronic SIBO symptoms: May be taken long-term as needed.

An example product containing Saccharomyces boulardii is Florastor (by Biocodex), which is one of the most well-studied S. boulardii brands.

Soil-based probiotics (Bacillus strains)

Soil-based probiotics (SBOs) are spore-forming bacteria that naturally exist in the environment. Unlike traditional Lactobacillus and Bifidobacterium probiotics, SBOs are highly resilient, surviving stomach acid, antibiotics, and harsh gut conditions.

This makes SBOs particularly useful for SIBO, as they:

  • Do not contribute to bacterial overgrowth in the small intestine.
  • Resist destruction by antibiotics, so they can be used during and after SIBO treatment.
  • Produce antimicrobial compounds, which may help control SIBO-related bacteria.

There are a lot of types of soil-based bacteria, but the most common species are:

  1. Bacillus Clausii
  2. Bacillus Coagulans
  3. Bacillus Subtilis
  4. Bacillus indicus
  5. Bacillus licheniformis

I want to clarify the benefits of using some of the safest and most effective species for gut health based on research, including Bacillus Clausii, Bacillus Coagulans, and Bacillus Subtilis.

Benefits of Soil-based probiotics for gut health
Bacillus clausii

Bacillus clausii is a spore-forming bacterium that is heat and shelf-stable.

Here are some of its benefits for gut health:

  • Helps reduce diarrhea - Evidence from clinical studies suggests that B. clausii shows effectiveness in preventing and treating diarrhea in adults and children, including diarrhea resulting from antibiotic treatment. (33)
  • Survives antibiotics & prevents dysbiosis (gut imbalance)- A clinical trial found that Bacillus clausii restored microbiome balance in patients taking antibiotics (34). Why it matters? Since SIBO is often treated with antibiotics, taking B. clausii during and after treatment may reduce side effects and prevent relapse.
  • Reduces IBS symptoms, boosts the immune system & reduces inflammation - B. clausii was shown to modulate the immune response and reduce gut inflammation in patients with IBS. They significantly reduced abdominal pain in children with IBS. (35) Many SIBO patients suffer from gut inflammation and immune dysfunction, making B. clausii a valuable strain for gut healing.
  • Helpful in SIBO eradication – a study involving 40 patients diagnosed with SIBO found that after taking Enterogermina for one month, 47% of participants showed a normalized glucose breath test result. (36)

General dosage & duration:

  • 5–10 billion CFU per day
  • Duration: 4–8 weeks, especially during & after antibiotic therapy

Example Product: Enterogermina (Sanofi) – One of the most well-studied B. clausii probiotics, commonly used with antibiotics.

Bacillus coagulans

It is the most studied soil-based probiotic. There have been quite a few studies on its effectiveness for IBS.

Key benefits for gut health:

  • Reduces digestive symptoms:
    • B. coagulans (MTCC 5856) was shown to have a positive effect on diarrhea in IBS patients. (37)
    • B. coagulans (GBI-30, 6086) was shown to relieve abdominal pain and bloating (38).
    • A clinical trial showed that Bacillus coagulans (SNZ 1969) increased gut motility and reduced constipation. (39)
  • A study suggests that GanedenBC30 (Bacillus coagulans) may aid in the digestion of lactose, fructose, and milk protein, potentially reducing intestinal symptoms in individuals sensitive to these carbohydrates. However, its effectiveness could be greater if more spores germinated. (40)
  • Effective for SIBO:
    • In a clinical trial involving 30 individuals with chronic abdominal pain or diarrhea and a positive hydrogen breath test (HBT) for SIBO, B. coagulans Unique IS-2 was found to be effective. After three weeks of antibiotic therapy, participants were given either B. coagulans Unique IS-2 or a placebo for 15 days alongside maintenance antibiotics. After six months, the probiotic group showed significant improvements:
      • Gastrointestinal symptoms like belching, flatulence, and diarrhea significantly improved.
      • Abdominal pain disappeared completely.
      • 93% of individuals in the probiotic group had negative hydrogen breath tests, compared to 67% in the placebo group. (41)

General dosage & duration:

  • 2–10 billion CFU per day
  • Duration: 6–8 weeks for symptom relief, but can be used long-term for gut support.

Example product: LactoSpore® (B. coagulans MTCC 5856)

Bacillus subtilis

Key benefits for gut health:

  • Improves gut motility – a study showed that B. Subtilis (DE111) improves occasional constipation and/or diarrhea in healthy individuals. (42)
  • Reduces gut symptoms – In another study, Bacillus subtilis MB40 (MB40) was shown to reduce bloating intensity, abdominal discomfort, and gas in healthy participants. (43)
  • Reduces abdominal pain – a study found that  Medilac DS (Bacillus subtilis with Streptococcus faecium) is a safe and useful probiotic agent for the treatment of abdominal pain in patients with IBS. (44)
  • Helps in H. Pylori eradication -  Supplementation with probiotic strains, composed of Bacillus subtilis and Streptococcus faecium, were shown to improve drug compliance, reduce side effects, and enhance the intention-to-treat eradication rate of Helicobacter pylori. (45)

General dosage & duration:

  • 1–4 billion CFU per day
  • Duration: 8–12 weeks for biofilm disruption

Example product: CoreBiotic (Researched Nutritionals) – Contains Bacillus subtilis along with other SBOs.

Are soil-based probiotics safe for SIBO?

There is some concern that certain soil-based probiotics (SBOs) may persist too long in the gut or pose risks for immunocompromised individuals.

However, well-researched strains like Bacillus clausii, Bacillus coagulans, and Bacillus subtilis have shown strong safety profiles and gut health benefits, particularly for reducing inflammation, supporting digestion, and balancing the gut microbiome.

While most studies focus on IBS rather than SIBO, the overlapping symptoms (bloating, diarrhea, constipation, abdominal pain) suggest that SBOs could offer similar benefits, particularly for bloating, motility issues, and microbiome repair after antibiotic therapy. Choosing clinically studied strains and monitoring tolerance is key to safely incorporating SBOs into a SIBO recovery plan.

If you don't want to experiment with soil-based probiotic supplements, you can expose yourself to them in a natural way through gardening, touching dirt, growing organic vegetables, and spending time outdoors.

How to take probiotics for SIBO without making symptoms worse

While probiotics can be incredibly beneficial for gut healing and microbiome balance, choosing the wrong product (especially multi-strain products) or introducing it too quickly may worsen bloating, gas, or discomfort. Plus, you may need to be extra careful if you suffer from histamine issues or have other immune system-related health challenges.

Here's how to safely incorporate probiotics into your SIBO treatment plan:

  • Start slow and low – Introduce one strain at a time and monitor symptoms. Gradually increase over 1–2 weeks, based on tolerance.
  • Choose products that clearly list the strains. - Each strain should be identified on the label. For example, not just Bacillus coagulans, but Bacillus coagulans MTCC 5856.
  • CFU count should be visible on the label – The label should specify billions of CFUs per dose.
  • Includes an expiration or manufacturing date – This ensures the bacteria remain viable.
  • Check the ingredient list – The product should be free from common allergens like gluten and dairy, and ideally, you want to have a product without added prebiotics (like inulin) if you have SIBO.
  • Manufactured under Good Manufacturing Practices (GMP) – This ensures safety and quality control.
  • Third-party tested – Independent lab verification confirms strain accuracy and potency.
  • Pair with other SIBO treatments – Probiotics alone won't cure SIBO. Use them alongside dietary and lifestyle changes, treatment, addressing the root causes, and prokinetics. It should be part of a holistic approach to SIBO.

Conclusion: should you use probiotics for SIBO?

The debate over probiotics for SIBO stems from concerns that adding more microbes to an already imbalanced small intestine could worsen symptoms. However, the research suggests otherwise—when the right probiotic strains are chosen, they can enhance treatment success, support microbiome recovery, and reduce relapse risk.

Certain probiotics, such as Saccharomyces boulardii and Bacillus clausii, are safe to use during antibiotic or herbal treatments, helping to prevent gut dysbiosis.

After treatment, soil-based probiotics (SBOs) like Bacillus coagulans and Bacillus subtilis can help restore microbial balance, improve motility, and strengthen the gut lining, reducing the likelihood of SIBO returning.

While most studies have focused on IBS rather than SIBO specifically, the overlap in symptoms suggests that probiotics can offer similar benefits in regulating bloating, stool consistency, and gut function. The key is to use well-researched strains, introduce them gradually, and listen to your body's response.

Verdict: Yes, probiotics can be a valuable tool for SIBO treatment and recovery—but only when carefully selected and strategically used.

This post is only for informational purposes and is not meant to diagnose, treat, or cure any disease. I recommend always consulting your healthcare practitioner before trying any treatment or dietary changes

References
 + -

References:

  1. Achufusi, T. G. O., Sharma, A., Zamora, E. A., & Manocha, D. (2020). Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods. Cureus, 12(6), e8860. https://doi.org/10.7759/cureus.8860
  2. Hill, C., Guarner, F., Reid, G. et al.The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11, 506–514 (2014). https://doi.org/10.1038/nrgastro.2014.66
  3. Bodke, H., & Jogdand, S. (2022). Role of Probiotics in Human Health. Cureus, 14(11), e31313. https://doi.org/10.7759/cureus.31313
  4. Kechagia, M., Basoulis, D., Konstantopoulou, S., Dimitriadi, D., Gyftopoulou, K., Skarmoutsou, N., & Fakiri, E. M. (2013). Health benefits of probiotics: a review. ISRN nutrition, 2013, 481651. https://doi.org/10.5402/2013/481651
  5. Gul, S., & Durante-Mangoni, E. (2024). Unraveling the Puzzle: Health Benefits of Probiotics—A Comprehensive Review. Journal of Clinical Medicine, 13(5), 1436. https://doi.org/10.3390/jcm13051436
  6. Pandey, K. R., Naik, S. R., & Vakil, B. V. (2015). Probiotics, prebiotics and synbiotics- a review. Journal of food science and technology, 52(12), 7577–7587. https://doi.org/10.1007/s13197-015-1921-1
  7. https://activatedprobiotics.com.au/wp-content/uploads/2024/06/AP_Histamine-Gene-Table_A4_DX.pdf
  8. Fijan S. (2023). Probiotics and Their Antimicrobial Effect. Microorganisms, 11(2), 528. https://doi.org/10.3390/microorganisms11020528
  9. Dimidi E, Christodoulides S, Scott SM, Whelan K. Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation. Adv Nutr. 2017 May 15;8(3):484-494. doi: 10.3945/an.116.014407. PMID: 28507013; PMCID: PMC5421123.
  10. Chen, W. C., & Quigley, E. M. (2014). Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: opening up a new therapeutic horizon!. The Indian journal of medical research, 140(5), 582–584.I https://pmc.ncbi.nlm.nih.gov/articles/PMC4311309/
  11. Soifer, L. O., Peralta, D., Dima, G., & Besasso, H. (2010). Eficacia comparativa de un probiótico vs un antibiótico en la respuesta clínica de pacientes con sobrecrecimiento bacteriano del intestino y distensión abdominal crónica funcional: un estudio piloto [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study]. Acta gastroenterologica Latinoamericana, 40(4), 323–327. I https://pubmed.ncbi.nlm.nih.gov/21381407/
  12. Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Silveri, N. G., & Gasbarrini, A. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. The American journal of gastroenterology, 104(5), 1327–1328. https://doi.org/10.1038/ajg.2009.91
  13. Ojetti, V., Petruzziello, C., Migneco, A., Gnarra, M., Gasbarrini, A., & Franceschi, F. (2017). Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. European review for medical and pharmacological sciences, 21(7), 1702–1708.
  14. Weizman, Z., Abu-Abed, J., & Binsztok, M. (2016). Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of pediatrics, 174, 160–164.e1. https://doi.org/10.1016/j.jpeds.2016.04.003
  15. Belei, O., Olariu, L., Dobrescu, A., Marcovici, T., & Marginean, O. (2018). Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?. Journal of neurogastroenterology and motility, 24(1), 51–57. https://doi.org/10.5056/jnm17059
  16. Mu, Q., Tavella, V. J., & Luo, X. M. (2018). Role of Lactobacillus reuteriin Human Health and Diseases. Frontiers in microbiology, 9, 757. https://doi.org/10.3389/fmicb.2018.00757
  17. Ojetti, V., Petruzziello, C., Migneco, A., Gnarra, M., Gasbarrini, A., & Franceschi, F. (2017). Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. European review for medical and pharmacological sciences, 21(7), 1702–1708.
  18. Cheng, J., Laitila, A., & Ouwehand, A. C. (2021). Bifidobacterium animalislactis HN019 Effects on Gut Health: A Review. Frontiers in nutrition, 8, 790561. https://doi.org/10.3389/fnut.2021.790561
  19. Waller, P. A., Gopal, P. K., Leyer, G. J., Ouwehand, A. C., Reifer, C., Stewart, M. E., & Miller, L. E. (2011). Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scandinavian journal of gastroenterology, 46(9), 1057–1064. https://doi.org/10.3109/00365521.2011.584895
  20. Ducrotté, P., Sawant, P., & Jayanthi, V. (2012). Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World journal of gastroenterology, 18(30), 4012–4018. https://doi.org/10.3748/wjg.v18.i30.4012
  21. Kaźmierczak-Siedlecka, K., Daca, A., Folwarski, M., Witkowski, J. M., Bryl, E., & Makarewicz, W. (2020). The role of Lactobacillus plantarum299v in supporting treatment of selected diseases. Central-European journal of immunology, 45(4), 488–493. https://doi.org/10.5114/ceji.2020.101515
  22. Malik, M., Suboc, T. M., Tyagi, S., Salzman, N., Wang, J., Ying, R., Tanner, M. J., Kakarla, M., Baker, J. E., & Widlansky, M. E. (2018). Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease. Circulation research, 123(9), 1091–1102. https://doi.org/10.1161/CIRCRESAHA.118.313565
  23. Stevenson, C., Blaauw, R., Fredericks, E., Visser, J., & Roux, S. (2014). Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Nutrition (Burbank, Los Angeles County, Calif.), 30(10), 1151–1157. https://doi.org/10.1016/j.nut.2014.02.010
  24. Krammer, H., Storr, M., Madisch, A., & Riffel, J. (2021). Reizdarmbehandlung mit Lactobacillus plantarum 299v: Längere Einnahme verstärkt Behandlungserfolg – Ergebnisse einer nichtinterventionellen Studie [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]. Zeitschrift fur Gastroenterologie, 59(2), 125–134. https://doi.org/10.1055/a-1340-0204
  25. Pais, P., Almeida, V., Yılmaz, M., & Teixeira, M. C. (2020). Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?. Journal of fungi (Basel, Switzerland), 6(2), 78. https://doi.org/10.3390/jof6020078
  26. García-Collinot, G., Madrigal-Santillán, E. O., Martínez-Bencomo, M. A., Carranza-Muleiro, R. A., Jara, L. J., Vera-Lastra, O., Montes-Cortes, D. H., Medina, G., & Cruz-Domínguez, M. P. (2020). Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. Digestive diseases and sciences, 65(4), 1134–1143. https://doi.org/10.1007/s10620-019-05830-0
  27. Efremova, I., Maslennikov, R., Zharkova, M., Poluektova, E., Benuni, N., Kotusov, A., Demina, T., Ivleva, A., Adzhieva, F., Krylova, T., & Ivashkin, V. (2024). Efficacy and Safety of a Probiotic Containing Saccharomyces boulardiiCNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study. Journal of clinical medicine, 13(3), 919. https://doi.org/10.3390/jcm13030919
  28. Billoo, A. G., Memon, M. A., Khaskheli, S. A., Murtaza, G., Iqbal, K., Saeed Shekhani, M., & Siddiqi, A. Q. (2006). Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World journal of gastroenterology, 12(28), 4557–4560. https://doi.org/10.3748/wjg.v12.i28.4557
  29. Bustos Fernández, L. M., Man, F., & Lasa, J. S. (2023). Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study. Digestive diseases (Basel, Switzerland), 41(5), 798–809. https://doi.org/10.1159/000528954
  30. Cayzeele-Decherf, A., Pélerin, F., Leuillet, S., Douillard, B., Housez, B., Cazaubiel, M., Jacobson, G. K., Jüsten, P., & Desreumaux, P. (2017). Saccharomyces cerevisiaeCNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World journal of gastroenterology, 23(2), 336–344. https://doi.org/10.3748/wjg.v23.i2.336
  31. Stier, H., & Bischoff, S. C. (2016). Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system. Clinical and experimental gastroenterology, 9, 269–279. https://doi.org/10.2147/CEG.S111003
  32. Kabbani, T. A., Pallav, K., Dowd, S. E., Villafuerte-Galvez, J., Vanga, R. R., Castillo, N. E., Hansen, J., Dennis, M., Leffler, D. A., & Kelly, C. P. (2017). Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut microbes, 8(1), 17–32. https://doi.org/10.1080/19490976.2016.1267890
  33. Acosta-Rodríguez-Bueno, C. P., Abreu Y Abreu, A. T., Guarner, F., Guno, M. J. V., Pehlivanoğlu, E., & Perez, M., 3rd (2022). Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review. Advances in therapy, 39(11), 4854–4874. https://doi.org/10.1007/s12325-022-02285-0
  34. Maity, C., & Gupta, A. K. (2021). Therapeutic efficacy of probiotic Alkalihalobacillus clausii088AE in antibiotic-associated diarrhea: A randomized controlled trial. Heliyon, 7(9), e07993. https://doi.org/10.1016/j.heliyon.2021.e07993
  35. Vázquez-Frias, R., Consuelo-Sánchez, A., Acosta-Rodríguez-Bueno, C. P., Blanco-Montero, A., Robles, D. C., Cohen, V., Márquez, D., & Perez, M., 3rd (2023). Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Paediatric drugs, 25(1), 115–126. https://doi.org/10.1007/s40272-022-00536-9
  36. Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Silveri, N. G., & Gasbarrini, A. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. The American journal of gastroenterology, 104(5), 1327–1328. https://doi.org/10.1038/ajg.2009.91
  37. Majeed, M., Nagabhushanam, K., Natarajan, S., Sivakumar, A., Ali, F., Pande, A., Majeed, S., & Karri, S. K. (2016). Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutrition journal, 15, 21. https://doi.org/10.1186/s12937-016-0140-6
  38. Hun L. (2009). Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgraduate medicine, 121(2), 119–124. https://doi.org/10.3810/pgm.2009.03.1984
  39. Kang, S., Park, M. Y., Brooks, I., Lee, J., Kim, S. H., Kim, J. Y., Oh, B., Kim, J. W., & Kwon, O. (2021). Spore-forming Bacillus coagulans SNZ 1969 improved intestinal motility and constipation perception mediated by microbial alterations in healthy adults with mild intermittent constipation: A randomized controlled trial. Food research international (Ottawa, Ont.), 146, 110428. https://doi.org/10.1016/j.foodres.2021.110428
  40. Maathuis, A. J., Keller, D., & Farmer, S. (2010). Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine. Beneficial microbes, 1(1), 31–36. https://doi.org/10.3920/BM2009.0009
  41. Gabrielli, M., Lauritano, E. C., Scarpellini, E., Lupascu, A., Ojetti, V., Gasbarrini, G., Silveri, N. G., & Gasbarrini, A. (2009). Bacillus clausii as a treatment of small intestinal bacterial overgrowth. The American journal of gastroenterology, 104(5), 1327–1328. https://doi.org/10.1038/ajg.2009.91
  42. Cuentas, A. M., Deaton, J., Davidson, J., Ardita, C. & Khan, S. The Effect of Bacillus subtilis DE111 on the Daily Bowel Movement Profile for People with Occasional Gastrointestinal Irregularity. Journal of Probiotics & Health 5, 1–4 (2017).
  43. Penet, C., Kramer, R., Little, R., Spears, J. L., Parker, J., Iyer, J. K., Guthrie, N., & Evans, M. (2021). A Randomized, Double-blind, Placebo-controlled, Parallel Study Evaluating the Efficacy of Bacillus subtilis MB40 to Reduce Abdominal Discomfort, Gas, and Bloating. Alternative therapies in health and medicine, 27(S1), 146–157.
  44. Kim, Y. G., Moon, J. T., Lee, K. M., Chon, N. R., & Park, H. (2006). The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 47(6), 413–419.
  45. Park, S. K., Park, D. I., Choi, J. S., Kang, M. S., Park, J. H., Kim, H. J., Cho, Y. K., Sohn, C. I., Jeon, W. K., & Kim, B. I. (2007). The effect of probiotics on Helicobacter pylori eradication. Hepato-gastroenterology, 54(79), 2032–2036.

Probiotics for SIBO – Do they Help or Harm? Read More »